Moderna to seek U.S., EU emergency authorization for Covid-19 vaccine

Moderna to seek U.S., EU emergency authorization for Covid-19 vaccine

Moderna Inc said it will apply for U.S. and European emergency authorization of its COVID-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns, Reuters reported.

“We believe that we have a vaccine that is very highly efficacious. We now have the data to prove it,” Moderna Chief Medical Officer Dr. Tal Zaks said in a telephone interview. “We expect to be playing a major part in turning around this pandemic.”

Moderna said it would apply for conditional approval from the European Medicines Agency.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

multimedia

news